Hualan Biological Bacterin Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,058.39 million compared to CNY 10.3 million a year ago. Revenue was CNY 1,060.56 million compared to CNY 10.91 million a year ago.

Net income was CNY 298.19 million compared to net loss of CNY 28.98 million a year ago. Basic earnings per share from continuing operations was CNY 0.7712 compared to basic loss per share from continuing operations of CNY 0.0805 a year ago. Diluted earnings per share from continuing operations was CNY 0.7712 compared to diluted loss per share from continuing operations of CNY 0.0805 a year ago.